Emanuela Porrello

Emanuela Porrello

Auto-generated profile, based on publicly available information

Emanuela Porrello

Department of Experimental and Applied Pharmacology, University of Pavia, Pavia, Italy

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in Development
Verified
Journal Article
Closed access
PDF file
DTDaniela Triolo
Daniela Triolo
GDGiorgia Dina
Giorgia Dina
CTCarla Taveggia
Carla Taveggia
IVIlaria Vaccari
Ilaria Vaccari
EPEmanuela Porrello
Emanuela Porrello
SPStefano Previtali
Stefano Previtali
Myelination is a complex process that requires coordinated Schwann cell-axon interactions during development and regeneration. Positive and negative regulators of myelination have been recently described, and can belong either to Schwann cells or neurons. Vimentin is a fibrous component present in both Schwann cell and neuron cytoskeleton, the expression of which is timely and spatially regulated during development and regeneration. We now report that vimentin negatively regulates myelination, as loss of vimentin results in peripheral nerve hypermyelination, owing to increased myelin thickness in vivo, in transgenic mice and in vitro in a myelinating co-culture system. We also show that this is due to a neuron-autonomous increase in the levels of axonal neuregulin 1 (NRG1) type III. Accordingly, genetic reduction of NRG1 type III in vimentin-null mice rescues hypermyelination. Finally, we demonstrate that vimentin acts synergistically with TACE, a negative regulator of NRG1 type III activity, as shown by hypermyelination of double Vim / Tace heterozygous mice. Our results reveal a novel role for the intermediate filament vimentin in myelination, and indicate vimentin as a regulator of NRG1 type III function.

29 June 2004 in European Journal of Biochemistry
Verified
Journal Article
Closed access
PDF file
Cristina LanniCristina Lanni
Cristina Lanni
MMMichela Mazzucchelli
Michela Mazzucchelli
EPEmanuela Porrello
Emanuela Porrello
SGStefano Govoni
Stefano Govoni
MRMarco Racchi
Marco Racchi

16 December 2013 in Journal of Experimental Medicine
Verified
Journal Article
Open access
EPEmanuela Porrello
Emanuela Porrello
CRCristina Rivellini
Cristina Rivellini
GDGiorgia Dina
Giorgia Dina
DTDaniela Triolo
Daniela Triolo
UCUbaldo Del Carro
Ubaldo Del Carro
SPStefano Previtali
Stefano Previtali
Axonal sorting is a crucial event in nerve formation and requires proper Schwann cell proliferation, differentiation, and contact with axons. Any defect in axonal sorting results in dysmyelinating peripheral neuropathies. Evidence from mouse models shows that axonal sorting is regulated by laminin211– and, possibly, neuregulin 1 (Nrg1)–derived signals. However, how these signals are integrated in Schwann cells is largely unknown. We now report that the nuclear Jun activation domain–binding protein 1 (Jab1) may transduce laminin211 signals to regulate Schwann cell number and differentiation during axonal sorting. Mice with inactivation of Jab1 in Schwann cells develop a dysmyelinating neuropathy with axonal sorting defects. Loss of Jab1 increases p27 levels in Schwann cells, which causes defective cell cycle progression and aberrant differentiation. Genetic down-regulation of p27 levels in Jab1-null mice restores Schwann cell number, differentiation, and axonal sorting and rescues the dysmyelinating neuropathy. Thus, Jab1 constitutes a regulatory molecule that integrates laminin211 signals in Schwann cells to govern cell cycle, cell number, and differentiation. Finally, Jab1 may constitute a key molecule in the pathogenesis of dysmyelinating neuropathies.

6 June 2006 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
EPE. Porrello
E. Porrello
CMCristina Montomoli
Cristina Montomoli
ESE. Sinforiani
E. Sinforiani
MCM. Cairati
M. Cairati
AGA. Guaita
A. Guaita
MRMarco Racchi
Marco Racchi

1 February 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CRCristina Rivellini
Cristina Rivellini
EPEmanuela Porrello
Emanuela Porrello
GDGiorgia Dina
Giorgia Dina
Simona Mrakic-SpostaSimona Mrakic-Sposta
Simona Mrakic-Sposta
AVAlessandra Vezzoli
Alessandra Vezzoli
SPStefano Previtali
Stefano Previtali
Oligodendrocytes are the primary target of demyelinating disorders, and progressive neurodegenerative changes may evolve in the CNS. DNA damage and oxidative stress are considered key pathogenic events, but the underlying molecular mechanisms remain unclear. Moreover, animal models do not fully recapitulate human diseases, complicating the path to effective treatments. Here we report that mice with cell-autonomous deletion of the nuclear COP9 signalosome component CSN5 (JAB1) in oligodendrocytes develop DNA damage and defective DNA repair in myelinating glial cells. Interestingly, oligodendrocytes lacking JAB1 expression underwent a senescence-like phenotype that fostered chronic inflammation and oxidative stress. These mutants developed progressive CNS demyelination, microglia inflammation, and neurodegeneration, with severe motor deficits and premature death. Notably, blocking microglia inflammation did not prevent neurodegeneration, whereas the deletion of p21CIP1 but not p16INK4a pathway ameliorated the disease. We suggest that senescence is key to sustaining neurodegeneration in demyelinating disorders and may be considered a potential therapeutic target.

29 July 2008 in Neurology
Verified
Journal Article
Closed access
PDF file
SPStefano Previtali
Stefano Previtali
MMM. C. Malaguti
M. C. Malaguti
NRNilo Riva
Nilo Riva
MSM. Scarlato
M. Scarlato
PDP. Dacci
P. Dacci
AQAngelo Quattrini
Angelo Quattrini
Objective: Recent evidence in animal models suggests that components of the extracellular matrix (ECM) play a primary role in peripheral nerve degeneration and regeneration. Methods: We investigated the expression of several ECM molecules in human sural nerves by immunohistochemistry, Western blot, and reverse transcriptase PCR analysis. To unravel the possible role of these molecules in nerve regeneration, we compared results obtained from nerves with abundant signs of regeneration with those with complete absence of axonal regeneration. The role of some ECM components on neurite extension was further tested in dorsal root ganglion cultures. Results: We observed that the ECM composition significantly differs in regenerating compared with nonregenerating nerves, independently from their etiologic background. Fibronectin was abundantly expressed in regenerating nerves, whereas vitronectin and fibrin(ogen) prevailed in nonregenerating nerves. Whereas fibronectin is secreted by endoneurial cells, in vivo and vitro studies showed that the source of vitronectin and fibrin(ogen) is the bloodstream. Conclusions: These data indicate that nerve regeneration is impaired in the presence of breaches in the blood–nerve barrier or impaired extracellular matrix (ECM) degradation that leads to accumulation of plasma vitronectin and fibrin(ogen). The transformation into mature, fibronectin-enriched ECM is necessary for efficient nerve regeneration in humans.